Global Induced Pluripotent Stem Cells market expected to grow 9.1% by 2028

From GlobeNewswire: 2025-01-22 13:55:00

According to BCC Research, the global market for Induced Pluripotent Stem Cells is projected to reach $5.2 billion by 2028, with a CAGR of 9.1% from 2023. The report analyzes application types, product functions, iPSC generation, and types of iPSC-derived cells and species. It also assesses market drivers, challenges, and opportunities.

Factors driving the market include the growing prevalence of chronic diseases, increasing investments in the biotech industry, surging demand for personalized medicines, and the need for drug discovery and development. iPSCs help develop new treatments, enable personalized therapies, and facilitate drug discovery through disease modeling.

Scientists use iPSC-derived cells to test medications, evaluate treatments for diseases like Alzheimer’s and Parkinson’s, study disease mechanisms, and replicate organ structures. Market leaders in iPSC research include NCARDIA, QIAGEN, and Thermo Fisher Scientific. To purchase a copy of the report, contact [email protected].

BCC Research provides market research reports that offer objective and unbiased analysis of market opportunities. Their experienced industry analysts aim to help businesses make informed decisions without noise or hype.



Read more at GlobeNewswire: Induced Pluripotent Stem Cells Industry Poised for 9.1%